TY  - JOUR

T1  - P3-093: Correlative analyses of plasma cytokine / angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of 1st-line vandetanib (VAN) and / or carboplatin plus paclitaxel (CP) for advanced non small cell lung cancer (NSCLC).

JO  - Journal of Thoracic Oncology

PY  - 2007/08/01

AU  - Heymach JV

AU  - Hanrahan EO

AU  - Lin HY

AU  - Du DZ

AU  - Yan S

AU  - Kim ES

AU  - Lee JJ

AU  - Ryan AJ

AU  - Tran HT

AU  - Johnson BE

ED  - 

DO  - DOI: 10.1097/01.jto.0000284069.35181.74

PB  - Elsevier

VL  - 2

IS  - 8

SP  - s718

Y2  - 2026/03/02

ER  -